Effect of beta blockers on the indices of acute phase response and level of circulating immune complexes in myocardial infarction
Korochkin, I.M.; Chukaeva, I.I.; Aleshkin, A.V.; Smolina, N.V.; Litvinova, S.N.; Aleksandrov, A.A.
Sovetskaya Meditsina 6: 45-47
1991
Accession: 031066203
PDF emailed within 1 workday: $29.90
Related References
Korochkin, I.M.; Chukaeva, I.I.; Aleshkin, A.V.; Smolina, N.V.; Litvinova, S.N.; Aleksandrov, A.A. 1991: Effects of beta blockers on the parameters of acute phase response and level of circulating immune complexes in myocardial infarct Sovetskaia Meditsina 6: 45-47Marcillac-Desruennes, M.; Weber, S.; Degeorges, M. 1984: Use of beta-blockers in the acute phase of myocardial infarction Annales de Cardiologie et d'Angeiologie 33(8): 519-523
Mrdovic, I.B. 2006: Is the level of evidence for the use of beta-blockers in acute myocardial infarction satisfactory enough? European heart journal 27(1): 118-9; author reply 119
Quiret, J.C. 1988: Les bêta-bloquants à la phase aiguë de l'infarctus du myocarde - Treatment of acute myocardial infarction with beta-blockers Gazette Medicale de France (1969) 95(12): 51-58
Leinonen, M.; Linnanmäki, E.; Mattila, K.; Nieminen, M.S.; Valtonen, V.; Leirisalo-Repo, M.; Saikku, P. 1990: Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction Microbial Pathogenesis 9(1): 67-73
Hauer, B.; Grison, D.; Favier, J.P.; Sacrez, A. 1985: Beta-blockers in the acute phase of myocardial infarction. Echographic study Annales de Cardiologie et d'Angeiologie 34(2): 75-81
Jarry, G.; Hermida, J.S.; Rey, J.L.; Avinée, P.; Quiret, J.C.; Bernasconi, P. 1990: Thrombolysis and intravenous beta-blockaders in the acute phase of myocardial infarction Annales de Cardiologie et d'Angeiologie 39(2): 83-88
Fesenko, I.T.; Vygovskii, V.P.; Yutanov, V.I.; Antonenko, L.N.; Cherkavskii, V.E. 1992: Circulating immune complexes and immunoglobulins in patients with acute macrofocal myocardial infarction Vrachebnoe Delo 1992(8): 69-71
Bonner, G.; Menzel, J.; Winkler, W.; Slany, J.; Steffen, C. 1989: Circulating immune complexes in acute myocardial infarction and in coronary heart disease European Heart Journal 10(ABSTR Suppl): 58
Bouvrain, Y.; Azancot, I.; Beaufils, P.; Masquet, C.; Thuillier, P.; Georgiopoulos, G. 1978: Value of beta-blockers during the acute phase of myocardial infarction. Actual status of the question and methodology La Nouvelle Presse Medicale 7(31): 2749-2752
Chapelle, M.J. 1978: Evaluation by echocardiography of the valve of beta-blockers in angina pectoris and in the acute phase of myocardial infarction La Nouvelle Presse Medicale 7(31): 2753-2758
Halkin, A.; Aymong, E.; Nikolsky, E.; Tcheng, J.E.; Rutherford, B.D.; Costantini, C.; Grines, C.L.; Stone, G.W. 2003: Marked survival benefit of peri-procedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty not previously treated with beta-blockers Circulation 108(17): IV467
Farrell, C.; Bloth, B.; Nielsen, H.; Daugharty, H.; Lundman, T.; Svehag, S.E. 1977: A survey for circulating immune complexes in patients with acute myocardial infarction. use of a C1q-binding assay with soluble protein a as indicator Scandinavian Journal of Immunology 6(12): 1233-1240
Korochkin, I.M.; Chukaeva, I.I.; Litvinova, S.N. 1985: Clinical importance of determining the level of circulating immune complexes in patients in the acute period of myocardial infarct Kardiologiia 25(2): 58-60
Held, P.H.; Yusuf, S. 1993: Effects of beta-blockers and calcium channel blockers in acute myocardial infarction European Heart Journal 14(Suppl): 18-25